Septodont

Name

Septodont

Legal name

SEPTODONT HOLDING

Website

https://septodontcorp.com

Company type

Private

Founded year

1932

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Dental Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Dental Equipment and Supplies Manufacturing (339114)

SIC

Pharmaceutical Preparations (2834), Dental Equipment & Supplies (3843)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industry

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)

Keywords

• Dental pharmaceuticals
• Injectable anesthetics
• Bioactive biomaterials
• Dental pain management
• Contract pharmaceutical manufacturing

Headquarters

HQ city

Saint-maur-des-fossés

HQ country

France

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Dental pharmaceutical products: Manufacturing and distribution of injectable and topical anesthetics, dental needles, anesthetic reversers, safety devices, syringes, and dental therapeutic products globally through direct sales and distribution partners.
2. CDMO pharmaceutical manufacturing services: Contract development and manufacturing services through Novocol Pharma, specializing in aseptic injectable filling and combined medical device assembly. Services include pharmaceutical filling, combined product assembly, drug development and analytical services, and drug delivery system design.
3. Biomaterials and endodontic products: Sale of proprietary bioactive materials including Biodentine™ products and BioRoot™ sealers for dental restoration and endodontic procedures.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Septodont develops, manufactures, and globally distributes pharmaceutical dental products centered on injectable local anesthetics (Septocaine/articaine), endodontic and restorative biomaterials (Biodentine™, BioRoot™ RCS/Flow based on proprietary Active BioSilicate Technology), dental needles, safety syringes, anesthetic reversers, and buffers. Through its Novocol Pharma division, the company also offers pharmaceutical Contract Development and Manufacturing Organization (CDMO) services, including aseptic injectable filling and combination product assembly for pharmaceutical and biotech partners such as Moderna.

Product overview

Septodont is a world leader in the development, manufacturing, and distribution of innovative dental products, operating both as a premium dental product manufacturer and as a pharmaceutical Contract Development and Manufacturing Organization (CDMO). Its portfolio centers on pain management (injectable and topical anesthetics such as Septocaine/Articaine, Oraverse, safety syringes, dental needles) and bioactive restorative solutions powered by its proprietary Active BioSilicate (ABS) Technology™ (Biodentine™, Biodentine™ XP, BioRoot™ RCS, BioRoot™ Flow). The company also manufactures buffers, synthetic membranes, and distributes acquired brands including Cook-Waite (US anesthetics) and Inibsa (dental pharmaceuticals). Its Novocol Pharma division serves as a global injectable CDMO.

Differentiator

Problem solved

Functional benefit

Brands

• TDV: Restoration accessories manufacturer based in Brazil
• DLA Pharma
• Novocol Pharma
• Biodentine
• BioRoot
• Cook-Waite
• Septocaine
• Oraverse

Products and services

• Septocaine (Articaine) Injectable articaine-based local dental anesthetic produced by Septodont, the world's largest individual manufacturer of articaine-based injectables, used by dental practitioners for pain management during procedures.
• Biodentine™ Bioactive dentin substitute and pulp therapeutic material, the first all-in-one product capable of entirely replacing dentin in both crown and root. Built on Septodont's proprietary Active BioSilicate (ABS) Technology™ platform, it has helped save 5 million teeth worldwide.
• Biodentine™ XP Advanced dentin substitute delivering the therapeutic benefits of Biodentine™ in a pre-dosed, ready-to-mix capsule format used with a mixer and dispensing gun, ideal for the Bio-Bulk Fill procedure for filling deep carious lesions in a single visit.
• BioRoot™ RCS Bioceramic root canal sealer based on tricalcium silicate technology that revolutionized cold obturation techniques, used in endodontic procedures by dental practitioners.
• BioRoot™ Flow Next-generation bioactive root canal sealer presented in a ready-to-use syringe, offering excellent clinical outcomes in both cold and warm obturation techniques with powerful adhesion and an outstanding hermetic seal.
• Oraverse The first local anesthesia reversal agent, acquired in 2011, enabling faster return to normal sensation and function after dental procedures for dental practitioners and their patients.
• Ultra Safety Plus Twist Safety syringe system designed to reduce needlestick injuries during dental procedures, providing dental practitioners with improved injection safety.
• Buffer Pro Innovative solution launched in 2025 for buffering local anesthetics before injection, designed to reduce injection discomfort and improve anesthetic effectiveness for dental practitioners.
• R.T.R.+ Membrane Synthetic membrane used in dental surgical procedures such as guided bone regeneration, for dental practitioners performing implantology and periodontal surgery.
• Dental Needles Dental needles manufactured at Septodont's dedicated SOFIC production site in France, sold to dental practitioners and clinics globally as a core ancillary to anesthetic delivery.
• Active BioSilicate (ABS) Technology™ Proprietary patented technology platform based on ultra-pure tricalcium silicate, developed over 10+ years of research and clinical collaboration, underpinning products such as Biodentine™ and BioRoot™ RCS. Protected by 120+ patents in 100+ countries.
• Novocol Pharma CDMO Services Contract Development and Manufacturing Organization services within Septodont, specializing in high-volume aseptic filling of injectable cartridges and combination product assembly. Serves pharmaceutical and biotech customers globally, including as Canada's partner with Moderna for filling and finishing respiratory mRNA vaccines.
• Cook-Waite Dental anesthetic brand serving the U.S. market, acquired by Septodont in 2017.

Quantifiable outcome

• 5 million teeth saved through Biodentine™ dentin restoration materials
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

23 partnerships are on record, tiered core and minor.

• DentroidcoreStrategic or Co-development Partner · 3 June 2026Global development and commercialization partnership to advance Dentroid's Nuralyte® technology using controlled light energy for largely needle-free pain management in common dental procedures. Combines Septodont's market leadership (30 anesthetic cartridges injected worldwide every second) with Dentroid's photonics-based platform to develop non-invasive dental pain solutions.
• Micro-MegacoreChannel Partner/ Reseller/ Distributor · 30 June 2025Strategic distribution partnership announced for endodontic products, combining Septodont's product portfolio with Micro-Mega's distribution capabilities.
• InibsacoreStrategic or Co-development Partner · 4 September 2024Septodont acquired a controlling stake in Inibsa, a global dental healthcare company based in Barcelona, Spain. Transaction aims to accelerate Inibsa's growth domestically in Iberia and globally, expanding Septodont's presence in the Spanish and Portuguese dental pharmaceutical markets.
• SanofiminorStrategic or Co-development Partner · 1 January 2021Acquisition of Sanofi's 4 dental product portfolio, expanding Septodont's product offerings.
• Novocol Pharma (Moderna)coreStrategic or Co-development Partner · 1 January 2014Novocol Pharma serves as Canada's partner with Moderna for the filling and finish of respiratory mRNA vaccines, demonstrating CDMO capabilities in aseptic pharmaceutical manufacturing.
• Immersify EducationminorGTM or Marketing PartnerEducational partnership providing interactive dental education platform with 3D simulated clinical cases, quizzes, and games covering topics like local anesthetic administration, pain management, dentin restoration, and Biodentine™ usage.
• World Health OrganizationminorStrategic or Co-development PartnerPartnership with international health bodies like WHO to renovate dental care centers and provide oral disease prevention training in Madagascar, Laos, and other underserved populations.
• Endodontic Aid International (AOI)minorStrategic or Co-development PartnerPartnership to improve percutaneous procedures in Laos and Madagascar, supporting healthcare safety in developing countries.
• SimplonminorStrategic or Co-development PartnerPartnership supporting digital skills training and professional pathways, helping launch Social Digital School in Val-de-Marne with 100 trainees gaining qualifications.
• America's ToothFairyminorStrategic or Co-development PartnerPartnership delivering preventative and restorative dental care, oral hygiene products, and education to underserved children in the US. Reached 2.9 million children since 2008.
• RoseUp AssociationminorStrategic or Co-development PartnerPartnership supporting women affected by cancer in France, providing financial assistance for classes, workshops, and events free of charge. Supported 426 women in 2022.
• Handicap InternationalminorStrategic or Co-development PartnerSupport for displaced people and humanitarian aid in Ukraine war, including emergency prosthetic limbs, wheelchairs, and psychosocial treatment.
• The Safe AssociationminorStrategic or Co-development PartnerPartnership providing medical supplies and logistics support for Ukraine, including use of Croissy-Beaubourg warehouse when their logistics arrangements collapsed.
• Bus Social DentaireminorStrategic or Co-development PartnerSolidarity dental buses equipped with dental care trays and volunteer dentists traveling to vulnerable communities in six European countries to provide free dental care.
• Order of MaltaminorStrategic or Co-development PartnerPartnership providing meals for 800 displaced children during Ukraine war, supporting their health, wellbeing, and education.
• Emmaüs SolidaritéminorStrategic or Co-development PartnerSupport for Ukrainian refugees' integration through French language skills and employment support in Val-de-Marne.
• Cop1 Solidarités EtudiantesminorStrategic or Co-development PartnerFunding for refrigerated van rental to distribute chilled produce to students in need in Paris, with connected oral care services.
• Louvre MuseumminorStrategic or Co-development PartnerProud patron supporting cultural heritage preservation, including development of la Chaire du Louvre lecture series and acquisition of cultural treasures.
• French National Library (BNF)minorStrategic or Co-development PartnerSupport for purchasing culturally important works of art, hosting literary lectures, and compiling provenance file with almost 300,000 records over 35 years.
• Science Based Targets initiative (SBTi)minorStrategic or Co-development PartnerPreparing near-term company-wide emissions-reduction target with SBTi including complementary Scope 3 target.
• Office National des Forêts (ONF)minorStrategic or Co-development PartnerThree-year agreement to plant 15,000 trees per year to restore ecosystems and support long-term forest preservation.
• Fondation de France and AnyamaminorStrategic or Co-development PartnerPartnership for sustainable forest management in 2024.
• 30+ academic universitiesminorStrategic or Co-development PartnerAcademic partnerships with prestigious universities worldwide providing access to products, facilities, and funding for research collaborations and evidence-based practice development.

Scale indicators17 records

Recent moves2 records

Expansion highlights8 records

Broad incumbents

• Dentsply Sirona: Dentsply Sirona is the world's largest diversified dental equipment and consumables manufacturer, with a portfolio spanning endodontic files (where Septodont competes via BioRoot and Micro-Mega partnership), imaging, CAD/CAM, and orthodontics. It is a broad incumbent in the same dental practitioner customer base that Septodont serves, with overlapping endodontic and consumables categories.
• 3M Oral Care: 3M's Oral Care division offers dental restoratives, preventive products, and orthodontic solutions—overlapping with Septodont's Biodentine line, dental needles (Septodont's SOFIC), and broader dental practitioner channel. As a broad incumbent in dental consumables, 3M competes for the same dental professional wallet share.
• Colgate-Palmolive (Professional Oral Health): Colgate-Palmolive's professional oral health division sells preventive and restorative products to dental professionals globally. As a broad incumbent with established dental practitioner relationships, it competes for share-of-wallet with Septodont's restorative and endodontic portfolio.
• Envista Holdings: Envista is a dental equipment and consumables platform (Nobel Biocare, Ormco, KaVo Kerr) that competes with Septodont across endodontic and restorative consumables. As a broad dental incumbent, it serves the same dental practitioner base and overlaps with Septodont's endodontic product line.

Regional players

• Henry Schein: Henry Schein is a leading dental supply distributor serving ~80% of US dental practices, distributing products from many manufacturers including dental anesthetic and endodontic brands. While not a direct product competitor, it is a major channel partner for dental practitioners globally—the same target customer Septodont serves with its branded portfolio.
• Patterson Companies: Patterson Companies is a US-focused dental and animal health supply distributor, serving dental practitioners across North America. It represents both a competitive threat (as a channel that could disintermediate) and a peer in serving the same end-dentist customer base with related consumables and equipment.

Direct peers

• Catalent: Catalent is a global CDMO specializing in softgel, oral dose, sterile injectable, and biologic fill-finish services. It directly competes with Septodont's Novocol Pharma division for aseptic injectable fill-finish contracts, including in the mRNA/biologics space where both serve top-tier pharma partners.
• Lonza: Lonza is the world's largest CDMO offering mammalian biologics, small molecules, and cell/gene therapy services with extensive aseptic fill-finish capacity. It directly competes with Novocol Pharma in sterile injectable manufacturing, particularly for high-value biologic and mRNA contracts.
• Recipharm: Recipharm (part of EQT/CD&R-owned arm) is a major European CDMO specializing in sterile injectables, blow-fill-seal, and small molecule manufacturing. It competes directly with Novocol Pharma for sterile injectable contract manufacturing in European and global markets.

Emerging players

• Align Technology: Align Technology (Invisalign) operates in the orthodontic clear aligner segment and increasingly intersects with dental practices through digital workflows. While its core product is different, Align is a credible adjacent peer in the dental practitioner value chain where Septodont's anesthetic and restorative products are also consumed.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@SeptodontGroup
• Facebookfacebook.com/septodontfrance
• LinkedInlinkedin.com/company/septodont-france
• Instagraminstagram.com/septodont
• Xx.com/SeptodontLtd

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Septodont